KANG [iKang Healthcare] SC 13E3/A: SCHEDULE 13E-3 AMENDMENT NO. 5 RULE 13e-3 TRANSACTION

[SCHEDULE 13E-3 AMENDMENT NO. 5 RULE 13e-3 TRANSACTION STATEMENT iKang Healthcare Group, Inc. (Name of the Issuer) iKang Healthcare Group, Inc. (Names of Persons Filing Statement) Class A Common Shares, par value US$0.01 per share American Depositary Shares, each representing 1/2 Class A Common Share]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Completion of Going Private Transaction Each record holder of Shares and registered holder of ADSs evidenced by American depositary receipts (“ADRs”) as of the effective time of the Merger who is entitled to the merger consideration will receive a letter of transmittal specifying how]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services mar]

KANG [iKang Healthcare] 6-K: iKang Announces Unaudited Financial Results for the Fiscal

[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services mar]

KANG [iKang Healthcare] 6-K: (Original Filing)

[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services mar]

KANG [iKang Healthcare] 6-K: iKang Announces Unaudited Financial Results for the Fiscal

[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services mar]

KANG [iKang Healthcare] SC 13D/A: (Original Filing)

[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]

KANG [iKang Healthcare] SC 13D/A: SCHEDULE 13D iKang Healthcare Group, Inc. (Name of

[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]

Skip to toolbar